131 related articles for article (PubMed ID: 2432740)
41. Pathogenicity of avian leukosis viruses.
Okazaki W; Purchase HG; Crittenden LB
Avian Dis; 1982; 26(3):553-9. PubMed ID: 6293446
[TBL] [Abstract][Full Text] [Related]
42. Sequences near the 5' long terminal repeat of avian leukosis viruses determine the ability to induce osteopetrosis.
Robinson HL; Reinsch SS; Shank PR
J Virol; 1986 Jul; 59(1):45-9. PubMed ID: 2423704
[TBL] [Abstract][Full Text] [Related]
43. Influence of env and long terminal repeat sequences on the tissue tropism of avian leukosis viruses.
Brown DW; Robinson HL
J Virol; 1988 Dec; 62(12):4828-31. PubMed ID: 2846895
[TBL] [Abstract][Full Text] [Related]
44. Immunization with envelope glycoprotein of an avian RNA tumor virus protects against sarcoma virus tumor induction: role of subgroup.
Bennett DD; Wright SE
Virus Res; 1987 Jul; 8(1):73-7. PubMed ID: 2821707
[TBL] [Abstract][Full Text] [Related]
45. [Antigen analysis of envelope gene products of avian leukosis virus subgroup J].
Qin A; Liu Y; Jin W; Lee L; Fadly A
Wei Sheng Wu Xue Bao; 2002 Feb; 42(1):99-104. PubMed ID: 12557356
[TBL] [Abstract][Full Text] [Related]
46. Antigenic determinants specific to the envelope glycoprotein of exogenous avian tumor viruses.
Marini SC; Friis RR; Helpern MS
J Virol; 1979 Feb; 29(2):805-7. PubMed ID: 85725
[TBL] [Abstract][Full Text] [Related]
47. Independent recombination between avian leukosis virus terminal sequences and host DNA in virus-induced proliferative disease.
Neiman P; Beemon K; Luce JA
Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1896-900. PubMed ID: 6262828
[TBL] [Abstract][Full Text] [Related]
48. Modifications in the binding domain of avian retrovirus envelope protein to redirect the host range of retroviral vectors.
Valsesia-Wittmann S; Drynda A; Deléage G; Aumailley M; Heard JM; Danos O; Verdier G; Cosset FL
J Virol; 1994 Jul; 68(7):4609-19. PubMed ID: 8207835
[TBL] [Abstract][Full Text] [Related]
49. Integration of different sarcoma virus genomes into host DNA: evidence against tandem arrangement and for shared integration sites.
Akiyama Y; Vogt PK
Proc Natl Acad Sci U S A; 1979 May; 76(5):2465-9. PubMed ID: 221927
[TBL] [Abstract][Full Text] [Related]
50. Development and characterization of monoclonal antibodies to subgroup A avian leukosis virus.
Qiu Y; Li X; Fu L; Cui Z; Li W; Wu Z; Sun S
Vet Comp Oncol; 2014 Mar; 12(1):47-51. PubMed ID: 23615298
[TBL] [Abstract][Full Text] [Related]
51. Viral sequences determining the oncogenicity of avian leukosis viruses.
Skalka AM; Tsichlis PN; Malavarca R; Cullen B; Ju G
Prog Clin Biol Res; 1983; 119():105-18. PubMed ID: 6306683
[TBL] [Abstract][Full Text] [Related]
52. Two different molecular defects in the Tva receptor gene explain the resistance of two tvar lines of chickens to infection by subgroup A avian sarcoma and leukosis viruses.
Elleder D; Melder DC; Trejbalova K; Svoboda J; Federspiel MJ
J Virol; 2004 Dec; 78(24):13489-500. PubMed ID: 15564460
[TBL] [Abstract][Full Text] [Related]
53. Sites of recombination between the transforming gene of avian myeloblastosis virus and its helper virus.
Kan NC; Baluda MA; Papas TS
Virology; 1985 Sep; 145(2):323-9. PubMed ID: 2992154
[TBL] [Abstract][Full Text] [Related]
54. Recombinant avian oncoviruses. II. Alterations in the gag proteins and evidence for intragenic recombination.
Shaikh R; Linial M; Brown S; Sen A; Eisenman R
Virology; 1979 Jan; 92(2):463-81. PubMed ID: 218355
[No Abstract] [Full Text] [Related]
55. Model of the TVA receptor determinants required for efficient infection by subgroup A avian sarcoma and leukosis viruses.
Melder DC; Pike GM; VanBrocklin MW; Federspiel MJ
J Virol; 2015 Feb; 89(4):2136-48. PubMed ID: 25473063
[TBL] [Abstract][Full Text] [Related]
56. Generation and evaluation of avian leukosis virus subgroup J envelope glycoprotein recombinant pseudovirions.
Zhang Z; Cui L; Wang L; Yang Z; Cui Z; Chang W
J Virol Methods; 2014 Jun; 202():1-7. PubMed ID: 24589516
[TBL] [Abstract][Full Text] [Related]
57. Antibody response to related leukosis viruses induced in chickens tolerant to an avian leukosis virus.
Meyers P
J Natl Cancer Inst; 1976 Feb; 56(2):381-6. PubMed ID: 176386
[TBL] [Abstract][Full Text] [Related]
58. Sequences outside of the long terminal repeat determine the lymphomogenic potential of Rous-associated virus type 1.
Robinson HL; Jensen L; Coffin JM
J Virol; 1985 Sep; 55(3):752-9. PubMed ID: 2991594
[TBL] [Abstract][Full Text] [Related]
59. Molecular basis of host range variation in avian retroviruses.
Dorner AJ; Stoye JP; Coffin JM
J Virol; 1985 Jan; 53(1):32-9. PubMed ID: 2981357
[TBL] [Abstract][Full Text] [Related]
60. Inter-relationship between genes controlling endogenous virus expression and those controlling susceptibility to exogenous RNA tumour viruses: evidence for linkage between the group specific antigen and tumour virus e loci.
Pani PK
J Gen Virol; 1978 Jan; 38(1):61-74. PubMed ID: 202672
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
